The Pulse
Visa put Hims into a dispute monitoring program.
Bloomberg reported on August 21 that Visa enrolled Hims & Hers in its Acquirer Monitoring Program after customer credit card disputes spiked in July.
Every dispute now carries an $8 surcharge. The first bill, close to $75,000, lands this month. To get out, Hims has to hold its dispute rate under 1.5% for three consecutive months.
The detail operators should sit with: internal documents reviewed by Bloomberg show the weight-loss business produced 75% of the disputes.
Chargebacks pool in the category where the patient's expectation and the card statement are furthest apart. That is a lifecycle problem showing up on a finance report.
Sword Health is buying Headspace, with a close expected September 14.
Sword Health, the virtual musculoskeletal care company, agreed to acquire OrangeDot, Headspace's parent, in an all-cash deal.
The news surfaced through a material change notice filed with the Massachusetts Health Policy Commission on July 22, which STAT reported on August 25. Fierce Healthcare and MobiHealthNews put the price at $200M to $300M, attributed to Axios Pro.
Single-condition digital health keeps folding into whole-person platforms, because that is what employer and payer buyers want to purchase.
If you sell one treatment category direct to patients, watch what this does to expectations. Bundled competitors make a one-condition subscription feel narrow.
Hims launched in Australia on August 31.
The company entered its first Asia-Pacific market by rebranding Pilot, the men's health platform it acquired with Eucalyptus, rather than building from zero. It is targeting $1B in international annual revenue within three years.
Worth noting how it got there. It bought a patient base instead of building one.
That is the fast path into a market, and also the one where you inherit somebody else's data, consent records and expectations.
The Deep Dive
The FTC sued Hims in late July over how it bills and how hard it is to cancel. That case will take years. Visa looked at the same customer behavior in July, ran one calculation, and had a penalty on the books by September.
Regulators get the attention, because a lawsuit comes with a complaint document and a press cycle.
The card networks are quieter and much faster.
1. The rule is arithmetic, and it already applies to you.
The threshold is 1.5% of transactions. Past it, $8 per dispute. Three consecutive months back under to get out.
Visa tightened that merchant threshold from 2.2% to 1.5% on April 1 this year. Brands that were comfortably inside the line in March were exposed in April without changing anything about how they operate.
And nobody has to file a complaint or name you publicly. Your acquirer just receives a report.
You can check yourself against this number today. Almost nobody does, because it arrives in a system the growth team never opens.
2. The number is produced by patients and scored by your processor.
75% of Hims' disputes came from one product line. Disputes never spread evenly across a catalog.
They pool where the distance is widest between what the patient thought they bought and what the statement says.
A dispute is what a patient does when the charge appears and they cannot place it, cannot stop it, or cannot get an answer fast enough to bother trying.
That moment usually sits about 30 days after the last thing the brand said to them.
So the people who could move the number work in lifecycle and support. The number itself lives in a finance report they have never been shown.
The fix is rarely a refund policy. It is knowing which charge, on which day, to which cohort, is generating the confusion.
3. At your size, the fine is not the penalty.
Hims is looking at roughly $75,000 and an unflattering headline. At $8 a dispute, that implies somewhere near 9,000 disputes in a single month (derived from the two reported figures, not reported directly).
A brand doing $8M a year does not get that bill. It gets a nervous acquirer, a rolling reserve held against its receipts, a high-risk merchant classification, and in the bad version, a processor that stops taking its volume.
Losing the ability to charge cards is not a line item. It stops revenue on a Tuesday.
Takeaway: Your dispute rate is now a compliance number with a published threshold and a price per unit. Find out what yours is before your acquirer is the one who tells you.
Quick Takes
Buying a local brand is a migration, not a launch.
Hims did not launch in Australia. It rebranded a platform it already owned and kept the patients on it.
That beats cold entry on speed. It also means inheriting someone else's consent records, sending reputation and flows written for a different brand promise.
Expansion by acquisition is a data migration project with a marketing launch attached to the front of it.
Your patients should not learn your company news from a filing.
The Sword and Headspace deal reached the market through a state regulatory filing, not an announcement.
When company news arrives from anywhere other than you, the first question every patient asks is whether their prescription changes. Support answers it one ticket at a time, at cost.
An acquisition, a price change or a formulary switch needs a message scheduled to go out ahead of the news, not after the tickets start.
One Thing to Try
Open your payment processor's dispute report for the last 90 days.
Divide disputes by settled transactions, month by month. If any month clears 1.5%, you are already at the number Visa uses to enroll merchants.
Then pull the dates. For each dispute, line the billing date up against the last message that patient received from you.
If most of those gaps run longer than two weeks, you do not have a billing problem. You have a calendar problem, and it costs less to fix than the chargebacks do.
Takes about 30 minutes. The report is already sitting in Stripe or Braintree.
If retention is your biggest revenue leak, that’s what we fix. growthtrigger.xyz
Reply to this with your biggest retention challenge. I read and respond to every single one.